Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL

Chronic myeloid leukemia (CML) is believed to be caused by the tyrosine kinase p210BCR-ABL, which exhibits growth-promoting and anti-apoptotic activities. However, mechanisms that allow cell differentiation in CML still remain elusive. Here we established tetracycline (Tet)-regulatable p210BCR-ABL-e...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Takita, Morichika, Tsukahara, Fujiko, Mishima, Taishi, Ieguchi, Katsuaki, Yamada, Masayuki, Honda, Hiroaki, Maru, Yoshiro
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2018
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6114964/
https://ncbi.nlm.nih.gov/pubmed/30167087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25849
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍